HSA
Hussman Strategic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,100
| Closed | -$1.33M | – | 278 |
|
|
2025
Q1 | $1.33M | Hold |
2,100
| – | – | 0.32% | 121 |
|
|
2024
Q4 | $1.5M | Buy |
+2,100
| New | +$1.5M | 0.44% | 94 |
|
|
2024
Q2 | – | Sell |
-2,100
| Closed | -$2.02M | – | 245 |
|
|
2024
Q1 | $2.02M | Sell |
2,100
-2,100
| -50% | -$2.02M | 0.47% | 85 |
|
|
2023
Q4 | $3.69M | Hold |
4,200
| – | – | 0.84% | 25 |
|
|
2023
Q3 | $3.46M | Sell |
4,200
-3,600
| -46% | -$2.96M | 0.66% | 34 |
|
|
2023
Q2 | $5.6M | Hold |
7,800
| – | – | 1.03% | 8 |
|
|
2023
Q1 | $6.41M | Hold |
7,800
| – | – | 1.01% | 5 |
|
|
2022
Q4 | $5.63M | Sell |
7,800
-1,500
| -16% | -$1.08M | 0.92% | 11 |
|
|
2022
Q3 | $6.41M | Sell |
9,300
-1,050
| -10% | -$723K | 1.11% | 6 |
|
|
2022
Q2 | $6.12M | Buy |
10,350
+4,110
| +66% | +$2.43M | 1.05% | 10 |
|
|
2022
Q1 | $4.36M | Buy |
6,240
+1,040
| +20% | +$726K | 0.85% | 13 |
|
|
2021
Q4 | $3.28M | Buy |
+5,200
| New | +$3.28M | 0.72% | 22 |
|
|
2020
Q3 | – | Sell |
-4,100
| Closed | -$2.56M | – | 300 |
|
|
2020
Q2 | $2.56M | Hold |
4,100
| – | – | 0.65% | 39 |
|
|
2020
Q1 | $2M | Buy |
4,100
+1,600
| +64% | +$781K | 0.54% | 56 |
|
|
2019
Q4 | $939K | Sell |
2,500
-2,500
| -50% | -$939K | 0.3% | 125 |
|
|
2019
Q3 | $1.39M | Hold |
5,000
| – | – | 0.39% | 96 |
|
|
2019
Q2 | $1.57M | Sell |
5,000
-2,500
| -33% | -$783K | 0.44% | 94 |
|
|
2019
Q1 | $3.08M | Buy |
+7,500
| New | +$3.08M | 0.75% | 36 |
|